Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price gapped up prior to trading on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $69.65, but opened at $86.35. Astera Labs shares last traded at $89.61, with a volume of 6,570,106 shares changing hands.
The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. The company had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. The firm's quarterly revenue was up 47.1% on a year-over-year basis.
Several research analysts have recently commented on ALAB shares. Morgan Stanley lifted their price target on Astera Labs from $55.00 to $74.00 and gave the stock an "overweight" rating in a report on Wednesday, October 9th. Evercore ISI reduced their target price on Astera Labs from $98.00 to $80.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. lowered their price target on Astera Labs from $95.00 to $70.00 and set an "overweight" rating for the company in a report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a "buy" rating in a research note on Tuesday. Finally, Craig Hallum lifted their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the company a "buy" rating in a report on Tuesday. Eleven analysts have rated the stock with a buy rating, Based on data from MarketBeat, Astera Labs currently has an average rating of "Buy" and an average price target of $81.00.
View Our Latest Analysis on ALAB
In related news, insider Sanjay Gajendra sold 110,000 shares of the stock in a transaction on Friday, October 11th. The stock was sold at an average price of $69.47, for a total value of $7,641,700.00. Following the completion of the sale, the insider now directly owns 835,000 shares in the company, valued at approximately $58,007,450. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Jack R. Lazar sold 3,000 shares of the company's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $61.69, for a total transaction of $185,070.00. Following the completion of the transaction, the director now directly owns 137,000 shares in the company, valued at $8,451,530. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sanjay Gajendra sold 110,000 shares of the firm's stock in a transaction on Friday, October 11th. The shares were sold at an average price of $69.47, for a total value of $7,641,700.00. Following the completion of the sale, the insider now owns 835,000 shares in the company, valued at $58,007,450. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 564,458 shares of company stock valued at $31,970,841 over the last 90 days.
Several hedge funds have recently bought and sold shares of ALAB. Jennison Associates LLC bought a new stake in Astera Labs during the first quarter worth approximately $11,283,000. Central Pacific Bank Trust Division acquired a new stake in shares of Astera Labs during the first quarter valued at approximately $402,000. Sei Investments Co. purchased a new stake in shares of Astera Labs in the 1st quarter valued at approximately $952,000. Lord Abbett & CO. LLC acquired a new position in Astera Labs in the 1st quarter worth approximately $33,141,000. Finally, Forge First Asset Management Inc. purchased a new position in Astera Labs during the 1st quarter worth approximately $1,143,000.
The firm's 50 day simple moving average is $54.88 and its 200-day simple moving average is $57.89.
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.